Protecting vision, advancing therapies
Kodiak Sciences (kodiak.com) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 62nd percentile of 17096 Healthcare brands.
Kodiak Sciences is a biopharmaceutical company headquartered in Palo Alto that develops next-generation therapies for retinal diseases. Its late-phase pipeline targets conditions such as diabetic retinopathy and age-related macular degeneration, aiming to protect and preserve patients' vision. The company positions itself as an innovator in retinal disease treatment, serving patients and the healthcare providers and specialists who treat them.
| Brand Name | Kodiak Sciences |
|---|---|
| Domain | kodiak.com |
| Industry | Healthcare |
| Headquarters | Palo Alto |
| Main Competitors | Regeneron Pharmaceuticals (92/100), Genentech (Roche) (84/100), Novartis (71/100), Apellis Pharmaceuticals (79/100), Regenxbio (74/100), Adverum Biotechnologies (82/100), Iveric Bio (49/100) |
Moz Domain Authority 41/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,299,067 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Kodiak Sciences appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Kodiak Sciences develops next-generation therapies for retinal diseases. Explore our late-phase pipeline across a broad spectrum of diseases." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, GitHub; no detected presence on YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Kodiak Sciences?", Claude could identify the brand as of September 2026. Kodiak Sciences is a clinical-stage biopharmaceutical company focused on developing therapies for retinal diseases, most notably wet age-related macular degeneration and diabetic macular edema. Its lead candidate, tarcocimab tedromer, is a long-acting anti-VEGF biologic designed Best known for Developing tarcocimab tedromer, a long-acting anti-VEGF therapy for retinal diseases like wet AMD.
When asked "Best brands similar to Kodiak Sciences?", Claude would recommend Kodiak Sciences as of September 2026. It's a notable player in the retinal disease treatment space with a distinctive long-acting biologic approach, making it relevant if someone is comparing biotech companies working on eye disease therapies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Kodiak Sciences's main competitors in Healthcare: Regeneron Pharmaceuticals (92/100), Genentech (Roche) (84/100), Novartis (71/100), Apellis Pharmaceuticals (79/100), Regenxbio (74/100).
Sources: Brand Analyzer scan
Kodiak Sciences has limited AI-search visibility, scoring 46/100 on Brand Analyzer's AI visibility composite (visibility 39, trust 49, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Kodiak Sciences official site
Kodiak Sciences is headquartered in Palo Alto. Kodiak Sciences operates in the Healthcare category.
Sources: Wikidata
Kodiak Sciences scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Kodiak Sciences official site
Kodiak Sciences is a biopharmaceutical company based in Palo Alto that develops next-generation therapies for retinal diseases.
Sources: Kodiak Sciences official site
Kodiak Sciences develops a late-phase pipeline of therapies designed to treat retinal diseases such as diabetic retinopathy and age-related macular degeneration, with the goal of protecting and preserving patients' vision.
Sources: Kodiak Sciences official site
Kodiak Sciences can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Kodiak Sciences official site
Kodiak Sciences' therapies are intended for patients suffering from retinal diseases such as diabetic retinopathy and age-related macular degeneration, and are used or prescribed by the healthcare providers and specialists who treat these conditions.
Sources: Kodiak Sciences official site
Kodiak Sciences scores 46/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Kodiak Sciences has a limited AI-visibility profile at 46/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (39/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,299,067 (Tranco) and a Moz Domain Authority of 41/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Kodiak Sciences from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Kodiak Sciences: Kitsap Mental Health Services (78/100), KlikDokter (78/100), Boundless (78/100), Konica Minolta Canada (78/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.